Alzheimer's affects tens of millions of people around the world and the goal of an effective treatment has been so elusive that it is seen as a 'black hole' for drugs spending. But now Andrew Ward and David Crow find fresh hope of a breakthrough

iTunes Stitcher audioBoom SoundCloud Overcast RSS


Copyright The Financial Times Limited 2017. All rights reserved.
myFT

Follow the topics related to this show

Comments have not been enabled for this podcast.